Mira Pharmaceuticals Inc (MIRA)

Date: O: H: L: C: Vol:

Finanzdaten der Mira Pharmaceuticals Inc-Aktie (MIRA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	4.77%1.16	1.10	5.82	1.32	1.55
Research and Development	34.49%0.71	0.52	0.50	0.41	0.50
Net Interest Income/Expense	21.78%0.04	0.04	0.05	0.02	-
Nonoperating Income/Loss	12.30%-0.05	-0.05	-0.16	0.18	-
	5.08%-1.21	-1.15	-5.98	-1.14	-1.54
Attributable To Parent	5.08%-1.21	-1.15	-5.98	-1.14	-1.54
Basic Average Shares	0.19%42.02	41.94	-	19.27	16.99
Basic Earnings Per Share	-0.03	-0.03	-	-1.18	-0.09
Diluted Earnings Per Share	-0.03	-0.03	-	-1.18	-0.09